JP2016525092A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016525092A5 JP2016525092A5 JP2016524330A JP2016524330A JP2016525092A5 JP 2016525092 A5 JP2016525092 A5 JP 2016525092A5 JP 2016524330 A JP2016524330 A JP 2016524330A JP 2016524330 A JP2016524330 A JP 2016524330A JP 2016525092 A5 JP2016525092 A5 JP 2016525092A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrrole
- methyl
- carboxylate
- octahydropyrrolo
- hexafluoropropan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 cyano, phenyl Chemical group 0.000 claims 112
- 125000000217 alkyl group Chemical group 0.000 claims 41
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 36
- WRHZVMBBRYBTKZ-UHFFFAOYSA-N pyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1 WRHZVMBBRYBTKZ-UHFFFAOYSA-N 0.000 claims 36
- 229910052736 halogen Inorganic materials 0.000 claims 30
- 150000002367 halogens Chemical class 0.000 claims 30
- 125000001424 substituent group Chemical group 0.000 claims 24
- 150000001875 compounds Chemical class 0.000 claims 19
- BQTIZWACTUVAGT-UHFFFAOYSA-N 2,3,3a,4,6,6a-hexahydro-1h-pyrrolo[3,4-c]pyrrole-5-carboxylic acid Chemical compound C1NCC2CN(C(=O)O)CC21 BQTIZWACTUVAGT-UHFFFAOYSA-N 0.000 claims 17
- 125000000753 cycloalkyl group Chemical group 0.000 claims 17
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 17
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 17
- 125000001188 haloalkyl group Chemical group 0.000 claims 16
- 125000003545 alkoxy group Chemical group 0.000 claims 14
- 229910052739 hydrogen Inorganic materials 0.000 claims 11
- 239000001257 hydrogen Substances 0.000 claims 11
- 125000004043 oxo group Chemical group O=* 0.000 claims 9
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- 125000004438 haloalkoxy group Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical class 0.000 claims 4
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- NSGXIBWMJZWTPY-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropane Chemical compound FC(F)(F)CC(F)(F)F NSGXIBWMJZWTPY-UHFFFAOYSA-N 0.000 claims 2
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 2
- QNNXBZWHBVZZTI-UHFFFAOYSA-N Cc1c(CN2CC3CN(CC3C2)C(O)=O)cccc1N1CCC(CC1)NS(C)(=O)=O Chemical compound Cc1c(CN2CC3CN(CC3C2)C(O)=O)cccc1N1CCC(CC1)NS(C)(=O)=O QNNXBZWHBVZZTI-UHFFFAOYSA-N 0.000 claims 2
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims 2
- 125000005549 heteroarylene group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 2
- SKKMNDJFMBCHFI-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[(2-fluoro-4-morpholin-4-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound FC1=CC(N2CCOCC2)=CC=C1CN(CC1C2)CC1CN2C(=O)ON1C(=O)CCC1=O SKKMNDJFMBCHFI-UHFFFAOYSA-N 0.000 claims 1
- GUDNOEUDNIYXST-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[(2-phenylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1C2CN(CC=3C(=CC=CC=3)C=3C=CC=CC=3)CC2CN1C(=O)ON1C(=O)CCC1=O GUDNOEUDNIYXST-UHFFFAOYSA-N 0.000 claims 1
- JVWFRPDSSLUJAL-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[(4-chloro-2-morpholin-4-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1COCCN1C1=CC(Cl)=CC=C1CN(CC1C2)CC1CN2C(=O)ON1C(=O)CCC1=O JVWFRPDSSLUJAL-UHFFFAOYSA-N 0.000 claims 1
- RBLUADGCZMXOAX-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[(4-chloro-2-pyrrolidin-1-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1CCCN1C1=CC(Cl)=CC=C1CN(CC1C2)CC1CN2C(=O)ON1C(=O)CCC1=O RBLUADGCZMXOAX-UHFFFAOYSA-N 0.000 claims 1
- WGCTUGFXQLBHFW-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[(4-fluoro-2-morpholin-4-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1COCCN1C1=CC(F)=CC=C1CN(CC1C2)CC1CN2C(=O)ON1C(=O)CCC1=O WGCTUGFXQLBHFW-UHFFFAOYSA-N 0.000 claims 1
- XTJHVWYAYOMXNW-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[(4-fluoro-2-pyrrolidin-1-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1CCCN1C1=CC(F)=CC=C1CN(CC1C2)CC1CN2C(=O)ON1C(=O)CCC1=O XTJHVWYAYOMXNW-UHFFFAOYSA-N 0.000 claims 1
- FLEDTRIQUOHVGQ-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[(4-propan-2-yl-2-pyrrolidin-1-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1CCCN1C1=CC(C(C)C)=CC=C1CN(CC1C2)CC1CN2C(=O)ON1C(=O)CCC1=O FLEDTRIQUOHVGQ-UHFFFAOYSA-N 0.000 claims 1
- OVTWKLNUMXQFBT-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[[2-(4-acetylpiperazin-1-yl)-4-chlorophenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1CN(C(=O)C)CCN1C1=CC(Cl)=CC=C1CN1CC2CN(C(=O)ON3C(CCC3=O)=O)CC2C1 OVTWKLNUMXQFBT-UHFFFAOYSA-N 0.000 claims 1
- KQCMGWLWNGILNW-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[[2-(4-acetylpiperazin-1-yl)-4-propan-2-ylphenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1CN(C(C)=O)CCN1C1=CC(C(C)C)=CC=C1CN(CC1C2)CC1CN2C(=O)ON1C(=O)CCC1=O KQCMGWLWNGILNW-UHFFFAOYSA-N 0.000 claims 1
- BYILKVNTBJWPED-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[[4-(4-acetylpiperazin-1-yl)-2-chlorophenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1CN(C(=O)C)CCN1C(C=C1Cl)=CC=C1CN1CC2CN(C(=O)ON3C(CCC3=O)=O)CC2C1 BYILKVNTBJWPED-UHFFFAOYSA-N 0.000 claims 1
- PGNNFIWBKRZBSS-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[[4-(4-acetylpiperazin-1-yl)-2-fluorophenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1CN(C(=O)C)CCN1C(C=C1F)=CC=C1CN1CC2CN(C(=O)ON3C(CCC3=O)=O)CC2C1 PGNNFIWBKRZBSS-UHFFFAOYSA-N 0.000 claims 1
- RMFWBQDASIAUGU-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[[4-chloro-2-(1-oxo-2,8-diazaspiro[4.5]decan-8-yl)phenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1CC2(C(NCC2)=O)CCN1C1=CC(Cl)=CC=C1CN(CC1C2)CC1CN2C(=O)ON1C(=O)CCC1=O RMFWBQDASIAUGU-UHFFFAOYSA-N 0.000 claims 1
- YQJQFUVBLIJOOX-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[[4-fluoro-2-(3-methylmorpholin-4-yl)phenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound CC1COCCN1C1=CC(F)=CC=C1CN1CC2CN(C(=O)ON3C(CCC3=O)=O)CC2C1 YQJQFUVBLIJOOX-UHFFFAOYSA-N 0.000 claims 1
- GNEAFYKODSFJMK-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[[4-morpholin-4-yl-2-(trifluoromethoxy)phenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound FC(F)(F)OC1=CC(N2CCOCC2)=CC=C1CN(CC1C2)CC1CN2C(=O)ON1C(=O)CCC1=O GNEAFYKODSFJMK-UHFFFAOYSA-N 0.000 claims 1
- MSKRXEICVNFEMQ-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 2-[bis(4-chlorophenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC(Cl)=CC=1)N1CC2CN(C(=O)ON3C(CCC3=O)=O)CC2C1 MSKRXEICVNFEMQ-UHFFFAOYSA-N 0.000 claims 1
- CIGBIGGDUAQRLU-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(1-ethyl-3-pyridin-3-ylpyrazol-4-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(CC)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C1=CC=CN=C1 CIGBIGGDUAQRLU-UHFFFAOYSA-N 0.000 claims 1
- ZQIRVRDHXCQWEF-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(2-cyclohexyl-5-methylpyrazol-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N1=C(C)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)N1C1CCCCC1 ZQIRVRDHXCQWEF-UHFFFAOYSA-N 0.000 claims 1
- OOYPIHJULVUGEB-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(2-cyclohexyl-5-propan-2-ylpyrazol-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N1=C(C(C)C)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)N1C1CCCCC1 OOYPIHJULVUGEB-UHFFFAOYSA-N 0.000 claims 1
- VSPCXZZEUGFDAL-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(2-methyl-3-morpholin-4-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound CC1=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=CC=C1N1CCOCC1 VSPCXZZEUGFDAL-UHFFFAOYSA-N 0.000 claims 1
- MEVQYEWUCLPVNX-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(2-methyl-3-piperidin-1-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound CC1=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=CC=C1N1CCCCC1 MEVQYEWUCLPVNX-UHFFFAOYSA-N 0.000 claims 1
- HPKSIINLLINMFO-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(2-phenylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1C2CN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2CN1CC1=CC=CC=C1C1=CC=CC=C1 HPKSIINLLINMFO-UHFFFAOYSA-N 0.000 claims 1
- FRRIOGDSAYLQBH-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(3-methyl-2-piperidin-1-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound CC1=CC=CC(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)=C1N1CCCCC1 FRRIOGDSAYLQBH-UHFFFAOYSA-N 0.000 claims 1
- HHSUBEJPQGJXKP-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(3-phenyl-1-propan-2-ylpyrazol-4-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(C(C)C)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C1=CC=CC=C1 HHSUBEJPQGJXKP-UHFFFAOYSA-N 0.000 claims 1
- BYLBIZIQXNAYTJ-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(4-fluoro-2-morpholin-4-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C=1C(F)=CC=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1N1CCOCC1 BYLBIZIQXNAYTJ-UHFFFAOYSA-N 0.000 claims 1
- YPFURSFOBNHDRO-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(4-phenylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1C2CN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2CN1CC(C=C1)=CC=C1C1=CC=CC=C1 YPFURSFOBNHDRO-UHFFFAOYSA-N 0.000 claims 1
- KIYXWQPEKDAVJF-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(4-propan-2-yl-2-pyrrolidin-1-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C=1C(C(C)C)=CC=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1N1CCCC1 KIYXWQPEKDAVJF-UHFFFAOYSA-N 0.000 claims 1
- GROSUVLLDKTZMY-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[(5-methyl-2-propan-2-ylpyrazol-3-yl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound CC(C)N1N=C(C)C=C1CN1CC2CN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2C1 GROSUVLLDKTZMY-UHFFFAOYSA-N 0.000 claims 1
- OZTNLWMHWOXZQO-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[1-ethyl-3-(3-morpholin-4-ylphenyl)pyrazol-4-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(CC)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C(C=1)=CC=CC=1N1CCOCC1 OZTNLWMHWOXZQO-UHFFFAOYSA-N 0.000 claims 1
- ZRWRFCSMVPWYKY-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[1-ethyl-3-(3-pyrrolidin-1-ylphenyl)pyrazol-4-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(CC)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C(C=1)=CC=CC=1N1CCCC1 ZRWRFCSMVPWYKY-UHFFFAOYSA-N 0.000 claims 1
- PFSDNZSZQQDAHC-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[1-ethyl-3-(4-morpholin-4-ylphenyl)pyrazol-4-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(CC)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C(C=C1)=CC=C1N1CCOCC1 PFSDNZSZQQDAHC-UHFFFAOYSA-N 0.000 claims 1
- ZYSXWYSHUIAXLB-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[1-methyl-3-(1-methylsulfonylpiperidin-4-yl)pyrazol-4-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(C)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C1CCN(S(C)(=O)=O)CC1 ZYSXWYSHUIAXLB-UHFFFAOYSA-N 0.000 claims 1
- GETJHMNSCNZETI-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[2-(1-acetylpiperidin-4-yl)-5-methylpyrazol-3-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1CN(C(=O)C)CCC1N1C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)=CC(C)=N1 GETJHMNSCNZETI-UHFFFAOYSA-N 0.000 claims 1
- RVRCFUYVXYANTH-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[2-(4-acetylpiperazin-1-yl)-4-chlorophenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1CN(C(=O)C)CCN1C1=CC(Cl)=CC=C1CN1CC2CN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2C1 RVRCFUYVXYANTH-UHFFFAOYSA-N 0.000 claims 1
- CERGHDKYTLVEHR-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[2-(4-acetylpiperazin-1-yl)-4-fluorophenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1CN(C(=O)C)CCN1C1=CC(F)=CC=C1CN1CC2CN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2C1 CERGHDKYTLVEHR-UHFFFAOYSA-N 0.000 claims 1
- CZPMRGQOYYDTSW-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[2-(oxan-4-yl)-5-propan-2-ylpyrazol-3-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N1=C(C(C)C)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)N1C1CCOCC1 CZPMRGQOYYDTSW-UHFFFAOYSA-N 0.000 claims 1
- UOAWPMBZAUBMSP-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[2-chloro-3-(2-oxa-7-azaspiro[4.4]nonan-7-yl)phenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1C2CN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2CN1CC(C=1Cl)=CC=CC=1N(C1)CCC21CCOC2 UOAWPMBZAUBMSP-UHFFFAOYSA-N 0.000 claims 1
- SFZXBXWVBSGAOM-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[2-chloro-4-(3-methylmorpholin-4-yl)phenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound CC1COCCN1C(C=C1Cl)=CC=C1CN1CC2CN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2C1 SFZXBXWVBSGAOM-UHFFFAOYSA-N 0.000 claims 1
- OZHJHXZHOURUFG-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[2-fluoro-4-(3-methylmorpholin-4-yl)phenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound CC1COCCN1C(C=C1F)=CC=C1CN1CC2CN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2C1 OZHJHXZHOURUFG-UHFFFAOYSA-N 0.000 claims 1
- XULMSYLPGIXWJY-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[2-morpholin-4-yl-3-(trifluoromethyl)phenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1C2CN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2CN1CC1=CC=CC(C(F)(F)F)=C1N1CCOCC1 XULMSYLPGIXWJY-UHFFFAOYSA-N 0.000 claims 1
- XCZZHWMKUIEVPV-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[3-(1-acetylpiperidin-4-yl)-1-propan-2-ylpyrazol-4-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(C(C)C)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C1CCN(C(C)=O)CC1 XCZZHWMKUIEVPV-UHFFFAOYSA-N 0.000 claims 1
- WZLWEMBYBYKOGV-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[3-(2-chlorophenyl)-1-methylpyrazol-4-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(C)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C1=CC=CC=C1Cl WZLWEMBYBYKOGV-UHFFFAOYSA-N 0.000 claims 1
- TWPJHBLVMSNEDV-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[3-(benzylcarbamoyl)-1-ethylpyrazol-4-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(CC)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C(=O)NCC1=CC=CC=C1 TWPJHBLVMSNEDV-UHFFFAOYSA-N 0.000 claims 1
- KTIOKMSYNNIURV-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[3-[2-(azetidin-1-yl)phenyl]-1-ethylpyrazol-4-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(CC)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C1=CC=CC=C1N1CCC1 KTIOKMSYNNIURV-UHFFFAOYSA-N 0.000 claims 1
- TTXFQHHMQSORNW-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[3-[3-(azetidin-1-yl)phenyl]-1-ethylpyrazol-4-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(CC)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C(C=1)=CC=CC=1N1CCC1 TTXFQHHMQSORNW-UHFFFAOYSA-N 0.000 claims 1
- IDQHUDZWTOQSTH-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[3-[4-(azetidin-1-yl)phenyl]-1-ethylpyrazol-4-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound N=1N(CC)C=C(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C=1C(C=C1)=CC=C1N1CCC1 IDQHUDZWTOQSTH-UHFFFAOYSA-N 0.000 claims 1
- TXGOQHZATMPXAT-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[3-chloro-2-(2-oxa-7-azaspiro[4.4]nonan-7-yl)phenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1C2CN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2CN1CC1=CC=CC(Cl)=C1N(C1)CCC21CCOC2 TXGOQHZATMPXAT-UHFFFAOYSA-N 0.000 claims 1
- DVHNNGNBGHJJLC-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-[[4-chloro-2-(1-oxo-2,8-diazaspiro[4.5]decan-8-yl)phenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylate Chemical compound C1C2CN(C(=O)OC(C(F)(F)F)C(F)(F)F)CC2CN1CC1=CC=C(Cl)C=C1N(CC1)CCC21CCNC2=O DVHNNGNBGHJJLC-UHFFFAOYSA-N 0.000 claims 1
- UZTQKMPRIOIRNR-UHFFFAOYSA-N 1-methyl-3-(3-methylphenyl)pyrazole Chemical compound CC1=CC=CC(C2=NN(C)C=C2)=C1 UZTQKMPRIOIRNR-UHFFFAOYSA-N 0.000 claims 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- LZDLJDUHSYJHOX-UHFFFAOYSA-N 2-[(4-chloro-2-morpholin-4-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylic acid Chemical compound C1COCCN1C2=C(C=CC(=C2)Cl)CN3CC4CN(CC4C3)C(=O)O LZDLJDUHSYJHOX-UHFFFAOYSA-N 0.000 claims 1
- SKUARWYQCHAPCH-UHFFFAOYSA-N 2-[(4-fluoro-2-pyrrolidin-1-ylphenyl)methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylic acid Chemical compound C1CCN(C1)C2=C(C=CC(=C2)F)CN3CC4CN(CC4C3)C(=O)O SKUARWYQCHAPCH-UHFFFAOYSA-N 0.000 claims 1
- UALXSLSJGTVQQX-UHFFFAOYSA-N 2-[[2-methyl-3-(2-oxa-7-azaspiro[4.4]nonan-7-yl)phenyl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylic acid Chemical compound CC1=C(C=CC=C1N2CCC3(C2)CCOC3)CN4CC5CN(CC5C4)C(=O)O UALXSLSJGTVQQX-UHFFFAOYSA-N 0.000 claims 1
- GQWXIYPQILXUBH-UHFFFAOYSA-N 2-[[3-(2-chlorophenyl)-1-propan-2-ylpyrazol-4-yl]methyl]-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole-5-carboxylic acid Chemical compound CC(C)N1C=C(C(=N1)C2=CC=CC=C2Cl)CN3CC4CN(CC4C3)C(=O)O GQWXIYPQILXUBH-UHFFFAOYSA-N 0.000 claims 1
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims 1
- SWBUHQQTIPEPMK-UHFFFAOYSA-N 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine Chemical compound C1NCCN2C=CN=C21 SWBUHQQTIPEPMK-UHFFFAOYSA-N 0.000 claims 1
- 125000004939 6-pyridyl group Chemical group N1=CC=CC=C1* 0.000 claims 1
- GFZFMAVOPMRLIP-UHFFFAOYSA-N 6h-pyrrolo[3,4-c]pyrrole-5-carboxylic acid Chemical compound N1=CC2=CN(C(=O)O)CC2=C1 GFZFMAVOPMRLIP-UHFFFAOYSA-N 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- CZZARJYCHNEGAX-UHFFFAOYSA-N C(C)(=O)NC1CCN(CC1)C=1C(=C(C=CC=1)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C Chemical compound C(C)(=O)NC1CCN(CC1)C=1C(=C(C=CC=1)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C CZZARJYCHNEGAX-UHFFFAOYSA-N 0.000 claims 1
- RZSYJHORVDWSJF-UHFFFAOYSA-N C(C)(C)(C)C1=NN(C(=C1)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C1=C(C=CC=C1)Cl Chemical compound C(C)(C)(C)C1=NN(C(=C1)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C1=C(C=CC=C1)Cl RZSYJHORVDWSJF-UHFFFAOYSA-N 0.000 claims 1
- DEJXUBLPXFOMAV-UHFFFAOYSA-N C(C)N1N=CC(=C1C(NCC1CCOCC1)=O)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F Chemical compound C(C)N1N=CC(=C1C(NCC1CCOCC1)=O)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F DEJXUBLPXFOMAV-UHFFFAOYSA-N 0.000 claims 1
- UBJRGUVLQUMIDM-UHFFFAOYSA-N C1(CC1)NC(=O)C1=C(C=NN1CC)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F Chemical compound C1(CC1)NC(=O)C1=C(C=NN1CC)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F UBJRGUVLQUMIDM-UHFFFAOYSA-N 0.000 claims 1
- AHDILOFKDQABLV-UHFFFAOYSA-N C1N(CC2C1CNC2)C(=O)OCC1=C(C=CC(=C1)Cl)N1CCC(CC1)NS(=O)(=O)C Chemical compound C1N(CC2C1CNC2)C(=O)OCC1=C(C=CC(=C1)Cl)N1CCC(CC1)NS(=O)(=O)C AHDILOFKDQABLV-UHFFFAOYSA-N 0.000 claims 1
- MNSKIBSAXCOHEX-UHFFFAOYSA-N CC(=O)N1CC2(C1)CCN(C2)c1ccccc1CN1CC2CN(CC2C1)C(=O)OC(C(F)(F)F)C(F)(F)F Chemical compound CC(=O)N1CC2(C1)CCN(C2)c1ccccc1CN1CC2CN(CC2C1)C(=O)OC(C(F)(F)F)C(F)(F)F MNSKIBSAXCOHEX-UHFFFAOYSA-N 0.000 claims 1
- CHXXOVYXYKOTMK-UHFFFAOYSA-N CC(=O)N1CCC(CC1)c1nn(C)cc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O Chemical compound CC(=O)N1CCC(CC1)c1nn(C)cc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O CHXXOVYXYKOTMK-UHFFFAOYSA-N 0.000 claims 1
- CGAPIKUJIZSSAR-UHFFFAOYSA-N CC(=O)N1CCC(CC1)c1nn(C)cc1CN1CC2CN(CC2C1)C(O)=O Chemical compound CC(=O)N1CCC(CC1)c1nn(C)cc1CN1CC2CN(CC2C1)C(O)=O CGAPIKUJIZSSAR-UHFFFAOYSA-N 0.000 claims 1
- DFVNPJQZDBKXTG-UHFFFAOYSA-N CC(=O)N1CCC(CC1)n1nc(C)cc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O Chemical compound CC(=O)N1CCC(CC1)n1nc(C)cc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O DFVNPJQZDBKXTG-UHFFFAOYSA-N 0.000 claims 1
- BPUBFNFQPDMMCM-UHFFFAOYSA-N CC(=O)N1CCC2(CCN(C2)c2ccccc2CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C1 Chemical compound CC(=O)N1CCC2(CCN(C2)c2ccccc2CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C1 BPUBFNFQPDMMCM-UHFFFAOYSA-N 0.000 claims 1
- CUXYWVOCOVLPJM-UHFFFAOYSA-N CC(=O)N1CCN(CC1)c1cc(F)ccc1CN1CC2CN(CC2C1)C(O)=O Chemical compound CC(=O)N1CCN(CC1)c1cc(F)ccc1CN1CC2CN(CC2C1)C(O)=O CUXYWVOCOVLPJM-UHFFFAOYSA-N 0.000 claims 1
- BVNHJLIJPARIQL-UHFFFAOYSA-N CC(=O)N1CCN(CC1)c1cccc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c1C Chemical compound CC(=O)N1CCN(CC1)c1cccc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c1C BVNHJLIJPARIQL-UHFFFAOYSA-N 0.000 claims 1
- JASJSPDQSZJWQE-UHFFFAOYSA-N CC(=O)NC1CCN(CC1)c1cccc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c1C Chemical compound CC(=O)NC1CCN(CC1)c1cccc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c1C JASJSPDQSZJWQE-UHFFFAOYSA-N 0.000 claims 1
- QBKYONMHOLMPKO-UHFFFAOYSA-N CC(C)(C)c1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)n(n1)C1CCOCC1 Chemical compound CC(C)(C)c1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)n(n1)C1CCOCC1 QBKYONMHOLMPKO-UHFFFAOYSA-N 0.000 claims 1
- XIVFGCVYCUATLZ-UHFFFAOYSA-N CC(C)c1cc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)n(n1)C1CCCCC1 Chemical compound CC(C)c1cc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)n(n1)C1CCCCC1 XIVFGCVYCUATLZ-UHFFFAOYSA-N 0.000 claims 1
- LHCAHECQLPJHBG-UHFFFAOYSA-N CC(C)c1ccc(CN2CC3CN(CC3C2)C(O)=O)c(c1)N1CCOCC1 Chemical compound CC(C)c1ccc(CN2CC3CN(CC3C2)C(O)=O)c(c1)N1CCOCC1 LHCAHECQLPJHBG-UHFFFAOYSA-N 0.000 claims 1
- UHGKMCPHDBUXCP-UHFFFAOYSA-N CC(C)n1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c(n1)-c1cccc(Cl)c1 Chemical compound CC(C)n1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c(n1)-c1cccc(Cl)c1 UHGKMCPHDBUXCP-UHFFFAOYSA-N 0.000 claims 1
- RRZNUXWSZAVPNE-UHFFFAOYSA-N CC(C)n1cc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(n1)-c1ccccc1Cl Chemical compound CC(C)n1cc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(n1)-c1ccccc1Cl RRZNUXWSZAVPNE-UHFFFAOYSA-N 0.000 claims 1
- NMZNVNVEUDQUHS-UHFFFAOYSA-N CC(C)n1cc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(n1)C1CCN(CC1)C(C)=O Chemical compound CC(C)n1cc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(n1)C1CCN(CC1)C(C)=O NMZNVNVEUDQUHS-UHFFFAOYSA-N 0.000 claims 1
- FTKMBTWHXULSOK-UHFFFAOYSA-N CC(C)n1nc(C)cc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O Chemical compound CC(C)n1nc(C)cc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O FTKMBTWHXULSOK-UHFFFAOYSA-N 0.000 claims 1
- DFQJXVHOYURMOT-UHFFFAOYSA-N CC1COCCN1c1cc(F)ccc1CN1CC2CN(CC2C1)C(O)=O Chemical compound CC1COCCN1c1cc(F)ccc1CN1CC2CN(CC2C1)C(O)=O DFQJXVHOYURMOT-UHFFFAOYSA-N 0.000 claims 1
- OVOMQSJIMDAZFW-UHFFFAOYSA-N CCN1CCN(CC1)c1c(C)cccc1CN1CC2CN(CC2C1)C(=O)OC(C(F)(F)F)C(F)(F)F Chemical compound CCN1CCN(CC1)c1c(C)cccc1CN1CC2CN(CC2C1)C(=O)OC(C(F)(F)F)C(F)(F)F OVOMQSJIMDAZFW-UHFFFAOYSA-N 0.000 claims 1
- WMYXZOHGCQVJEK-UHFFFAOYSA-N CCN1CCN(CC1)c1c(C)cccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O Chemical compound CCN1CCN(CC1)c1c(C)cccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O WMYXZOHGCQVJEK-UHFFFAOYSA-N 0.000 claims 1
- FHTFKUFBHRUVFW-UHFFFAOYSA-N CCN1CCN(CC1)c1cccc(CN2CC3CN(CC3C2)C(=O)OC2C(=O)CCC2=O)c1C Chemical compound CCN1CCN(CC1)c1cccc(CN2CC3CN(CC3C2)C(=O)OC2C(=O)CCC2=O)c1C FHTFKUFBHRUVFW-UHFFFAOYSA-N 0.000 claims 1
- ODKWUTKJIDYQRF-UHFFFAOYSA-N CCc1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)n(n1)-c1ccccc1Cl Chemical compound CCc1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)n(n1)-c1ccccc1Cl ODKWUTKJIDYQRF-UHFFFAOYSA-N 0.000 claims 1
- JATDGBDAMOBKAW-UHFFFAOYSA-N CCc1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)n(n1)C1CCOCC1 Chemical compound CCc1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)n(n1)C1CCOCC1 JATDGBDAMOBKAW-UHFFFAOYSA-N 0.000 claims 1
- MNMLODISMNINDA-UHFFFAOYSA-N CCn1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c(n1)-c1ccc(cc1)N1CCCCC1 Chemical compound CCn1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c(n1)-c1ccc(cc1)N1CCCCC1 MNMLODISMNINDA-UHFFFAOYSA-N 0.000 claims 1
- BLAJADABSUKRBX-UHFFFAOYSA-N CCn1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c(n1)-c1ccccc1N1CCCCC1 Chemical compound CCn1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c(n1)-c1ccccc1N1CCCCC1 BLAJADABSUKRBX-UHFFFAOYSA-N 0.000 claims 1
- JXBTWPULJMGWPM-UHFFFAOYSA-N CCn1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c(n1)-c1ccccc1N1CCOCC1 Chemical compound CCn1cc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c(n1)-c1ccccc1N1CCOCC1 JXBTWPULJMGWPM-UHFFFAOYSA-N 0.000 claims 1
- ZAYNYZHBQOSGFI-UHFFFAOYSA-N CN1CCN(CC1)c1c(C)cccc1CN1CC2CN(CC2C1)C(=O)OC(C(F)(F)F)C(F)(F)F Chemical compound CN1CCN(CC1)c1c(C)cccc1CN1CC2CN(CC2C1)C(=O)OC(C(F)(F)F)C(F)(F)F ZAYNYZHBQOSGFI-UHFFFAOYSA-N 0.000 claims 1
- RTPZFBRQWOMQPX-UHFFFAOYSA-N CN1CCN(CC1)c1c(C)cccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O Chemical compound CN1CCN(CC1)c1c(C)cccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O RTPZFBRQWOMQPX-UHFFFAOYSA-N 0.000 claims 1
- VUIXREFOAFEAPS-UHFFFAOYSA-N CN1CCN(CC1)c1cccc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c1C Chemical compound CN1CCN(CC1)c1cccc(CN2CC3CN(CC3C2)C(=O)OC(C(F)(F)F)C(F)(F)F)c1C VUIXREFOAFEAPS-UHFFFAOYSA-N 0.000 claims 1
- QABYOPQMCCTNLZ-UHFFFAOYSA-N CN1CCN(CC1)c1cccc(CN2CC3CN(CC3C2)C(=O)OC2C(=O)CCC2=O)c1C Chemical compound CN1CCN(CC1)c1cccc(CN2CC3CN(CC3C2)C(=O)OC2C(=O)CCC2=O)c1C QABYOPQMCCTNLZ-UHFFFAOYSA-N 0.000 claims 1
- SHGDQUDFFVUGST-UHFFFAOYSA-N CN1N=C(C(=C1)CN1CC2C(C1)CN(C2)C(=O)ON2C(CCC2=O)=O)C2=CC=CC=C2 Chemical compound CN1N=C(C(=C1)CN1CC2C(C1)CN(C2)C(=O)ON2C(CCC2=O)=O)C2=CC=CC=C2 SHGDQUDFFVUGST-UHFFFAOYSA-N 0.000 claims 1
- ILSPQYWWMKBXRY-UHFFFAOYSA-N CN1N=C(C=C1CN1CC2C(C1)CN(C2)C(=O)ON2C(CCC2=O)=O)C2=CC=CC=C2 Chemical compound CN1N=C(C=C1CN1CC2C(C1)CN(C2)C(=O)ON2C(CCC2=O)=O)C2=CC=CC=C2 ILSPQYWWMKBXRY-UHFFFAOYSA-N 0.000 claims 1
- MXDQCWQQNUWIND-UHFFFAOYSA-N CS(=O)(=O)N1CCN(CC1)c1cc(Cl)ccc1CN1CC2CN(CC2C1)C(=O)OC(C(F)(F)F)C(F)(F)F Chemical compound CS(=O)(=O)N1CCN(CC1)c1cc(Cl)ccc1CN1CC2CN(CC2C1)C(=O)OC(C(F)(F)F)C(F)(F)F MXDQCWQQNUWIND-UHFFFAOYSA-N 0.000 claims 1
- KECJUFQKEMLDBE-UHFFFAOYSA-N CS(=O)(=O)N1CCN(CC1)c1cc(Cl)ccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O Chemical compound CS(=O)(=O)N1CCN(CC1)c1cc(Cl)ccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O KECJUFQKEMLDBE-UHFFFAOYSA-N 0.000 claims 1
- BKUGHAIWCRPYRD-UHFFFAOYSA-N Cc1c(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)cccc1N1CCC(F)(F)CC1 Chemical compound Cc1c(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)cccc1N1CCC(F)(F)CC1 BKUGHAIWCRPYRD-UHFFFAOYSA-N 0.000 claims 1
- URMGXBVWRAZWMU-UHFFFAOYSA-N Cc1c(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)cccc1N1CCN(CC1)S(C)(=O)=O Chemical compound Cc1c(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)cccc1N1CCN(CC1)S(C)(=O)=O URMGXBVWRAZWMU-UHFFFAOYSA-N 0.000 claims 1
- AVLPKHNDVNDYOC-UHFFFAOYSA-N Cc1cccc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c1N1CCCCC1 Chemical compound Cc1cccc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c1N1CCCCC1 AVLPKHNDVNDYOC-UHFFFAOYSA-N 0.000 claims 1
- VWQGUYVIBBRZHN-UHFFFAOYSA-N ClC1=C(CN2CC3C(C2)CN(C3)C(=O)ON2C(CCC2=O)=O)C=CC(=C1)C(=O)N1CCCC1 Chemical compound ClC1=C(CN2CC3C(C2)CN(C3)C(=O)ON2C(CCC2=O)=O)C=CC(=C1)C(=O)N1CCCC1 VWQGUYVIBBRZHN-UHFFFAOYSA-N 0.000 claims 1
- NIOJMAQEUFECIQ-UHFFFAOYSA-N ClC1=C(CN2CC3C(C2)CN(C3)C(=O)ON2C(CCC2=O)=O)C=CC(=C1)C(=O)N1CCN(CC1)C Chemical compound ClC1=C(CN2CC3C(C2)CN(C3)C(=O)ON2C(CCC2=O)=O)C=CC(=C1)C(=O)N1CCN(CC1)C NIOJMAQEUFECIQ-UHFFFAOYSA-N 0.000 claims 1
- RWPDKIOERSRLRE-UHFFFAOYSA-N ClC1=C(CN2CC3C(C2)CN(C3)C(=O)ON2C(CCC2=O)=O)C=CC(=C1)C(=O)N1CCOCC1 Chemical compound ClC1=C(CN2CC3C(C2)CN(C3)C(=O)ON2C(CCC2=O)=O)C=CC(=C1)C(=O)N1CCOCC1 RWPDKIOERSRLRE-UHFFFAOYSA-N 0.000 claims 1
- CQQXADPTIFZTKE-UHFFFAOYSA-N ClC=1C(=C(C=CC=1)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F)N1CCC(CC1)F Chemical compound ClC=1C(=C(C=CC=1)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F)N1CCC(CC1)F CQQXADPTIFZTKE-UHFFFAOYSA-N 0.000 claims 1
- RDOPZPZOSOHXKO-IUDNXUCKSA-N ClC=1C(=C(C=CC=1)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F)N1C[C@H](CC1)CF Chemical compound ClC=1C(=C(C=CC=1)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F)N1C[C@H](CC1)CF RDOPZPZOSOHXKO-IUDNXUCKSA-N 0.000 claims 1
- ZTYUYAXAANGDKB-UHFFFAOYSA-N ClC=1C=C(C=CC1)CCNC(=O)C1=C(C=NN1CC)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F Chemical compound ClC=1C=C(C=CC1)CCNC(=O)C1=C(C=NN1CC)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F ZTYUYAXAANGDKB-UHFFFAOYSA-N 0.000 claims 1
- VJLUFGHHTCAAMS-UHFFFAOYSA-N Clc1ccc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(c1)N1CCC(CC1)C(=O)N1CCCC1 Chemical compound Clc1ccc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(c1)N1CCC(CC1)C(=O)N1CCCC1 VJLUFGHHTCAAMS-UHFFFAOYSA-N 0.000 claims 1
- KVUAMUFSOPPQQK-UHFFFAOYSA-N Clc1ccc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(c1)N1CCC1 Chemical compound Clc1ccc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(c1)N1CCC1 KVUAMUFSOPPQQK-UHFFFAOYSA-N 0.000 claims 1
- SPAZHRICOJJUBI-UHFFFAOYSA-N Clc1ccc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(c1)N1Cc2cccnc2C1 Chemical compound Clc1ccc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(c1)N1Cc2cccnc2C1 SPAZHRICOJJUBI-UHFFFAOYSA-N 0.000 claims 1
- GMCLQTMGVKLSNU-UHFFFAOYSA-N Cn1cc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(n1)-c1ccccc1Cl Chemical compound Cn1cc(CN2CC3CN(CC3C2)C(=O)ON2C(=O)CCC2=O)c(n1)-c1ccccc1Cl GMCLQTMGVKLSNU-UHFFFAOYSA-N 0.000 claims 1
- 201000010374 Down Syndrome Diseases 0.000 claims 1
- CMJNRHVBKMGVHP-UHFFFAOYSA-N FC(F)(F)C(OC(=O)N1CC2CN(Cc3cccc(Cl)c3)CC2C1)C(F)(F)F Chemical compound FC(F)(F)C(OC(=O)N1CC2CN(Cc3cccc(Cl)c3)CC2C1)C(F)(F)F CMJNRHVBKMGVHP-UHFFFAOYSA-N 0.000 claims 1
- ZALUANUKBRAJFU-UHFFFAOYSA-N FC(F)(F)C(OC(=O)N1CC2CN(Cc3cccc(N4CCC5(CCOC5)C4)c3C(F)(F)F)CC2C1)C(F)(F)F Chemical compound FC(F)(F)C(OC(=O)N1CC2CN(Cc3cccc(N4CCC5(CCOC5)C4)c3C(F)(F)F)CC2C1)C(F)(F)F ZALUANUKBRAJFU-UHFFFAOYSA-N 0.000 claims 1
- GITJBFIWRVWUSS-UHFFFAOYSA-N FC(F)(F)C(OC(=O)N1CC2CN(Cc3cccc(N4CCOCC4)c3C(F)(F)F)CC2C1)C(F)(F)F Chemical compound FC(F)(F)C(OC(=O)N1CC2CN(Cc3cccc(N4CCOCC4)c3C(F)(F)F)CC2C1)C(F)(F)F GITJBFIWRVWUSS-UHFFFAOYSA-N 0.000 claims 1
- XGIPKPKBHNEYIE-UHFFFAOYSA-N FC(F)(F)C(OC(=O)N1CC2CN(Cc3cccc(c3)-c3ccccc3)CC2C1)C(F)(F)F Chemical compound FC(F)(F)C(OC(=O)N1CC2CN(Cc3cccc(c3)-c3ccccc3)CC2C1)C(F)(F)F XGIPKPKBHNEYIE-UHFFFAOYSA-N 0.000 claims 1
- ATEFTWVRPBIKII-UHFFFAOYSA-N FC(F)(F)C(OC(=O)N1CC2CN(Cc3ccccc3Cl)CC2C1)C(F)(F)F Chemical compound FC(F)(F)C(OC(=O)N1CC2CN(Cc3ccccc3Cl)CC2C1)C(F)(F)F ATEFTWVRPBIKII-UHFFFAOYSA-N 0.000 claims 1
- JHTYOOFKIVEYFF-UHFFFAOYSA-N FC1=C(CN2CC3C(C2)CN(C3)C(=O)ON2C(CCC2=O)=O)C=CC(=C1)C(=O)N1CCCC1 Chemical compound FC1=C(CN2CC3C(C2)CN(C3)C(=O)ON2C(CCC2=O)=O)C=CC(=C1)C(=O)N1CCCC1 JHTYOOFKIVEYFF-UHFFFAOYSA-N 0.000 claims 1
- QWTJUCPZCOIYSO-UHFFFAOYSA-N FC1CCN(CC1)c1c(Cl)cccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O Chemical compound FC1CCN(CC1)c1c(Cl)cccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O QWTJUCPZCOIYSO-UHFFFAOYSA-N 0.000 claims 1
- PKFXUWBWCICFQU-UHFFFAOYSA-N Fc1cc(ccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O)C(=O)N1CCC1 Chemical compound Fc1cc(ccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O)C(=O)N1CCC1 PKFXUWBWCICFQU-UHFFFAOYSA-N 0.000 claims 1
- GUEPXWACWXUFAA-UHFFFAOYSA-N Fc1cc(ccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O)C(=O)N1CCCCC1 Chemical compound Fc1cc(ccc1CN1CC2CN(CC2C1)C(=O)ON1C(=O)CCC1=O)C(=O)N1CCCCC1 GUEPXWACWXUFAA-UHFFFAOYSA-N 0.000 claims 1
- 150000001204 N-oxides Chemical class 0.000 claims 1
- WZQCEOGJHUGEHM-UHFFFAOYSA-N N1(CCOCC1)C1=CC(=C(C=C1)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C(F)(F)F Chemical compound N1(CCOCC1)C1=CC(=C(C=C1)CN1CC2C(C1)CN(C2)C(=O)OC(C(F)(F)F)C(F)(F)F)C(F)(F)F WZQCEOGJHUGEHM-UHFFFAOYSA-N 0.000 claims 1
- IYBRDNIYDIMXHU-UHFFFAOYSA-N O=C(ON1C(=O)CCC1=O)N1CC2CN(Cc3cccc(c3)-c3ccccc3)CC2C1 Chemical compound O=C(ON1C(=O)CCC1=O)N1CC2CN(Cc3cccc(c3)-c3ccccc3)CC2C1 IYBRDNIYDIMXHU-UHFFFAOYSA-N 0.000 claims 1
- DZVOJFPNKWVRSH-UHFFFAOYSA-N OC(=O)N1CC2CN(Cc3ccc(cc3)-c3ccccc3)CC2C1 Chemical compound OC(=O)N1CC2CN(Cc3ccc(cc3)-c3ccccc3)CC2C1 DZVOJFPNKWVRSH-UHFFFAOYSA-N 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 claims 1
- 244000250129 Trigonella foenum graecum Species 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 125000000732 arylene group Chemical group 0.000 claims 1
- 125000004566 azetidin-1-yl group Chemical group N1(CCC1)* 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000001064 morpholinomethyl group Chemical group [H]C([H])(*)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000005551 pyridylene group Chemical group 0.000 claims 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 125000003003 spiro group Chemical group 0.000 claims 1
- RZJBKZOZVVCNBR-UHFFFAOYSA-N sulfamoyl bromide Chemical compound NS(Br)(=O)=O RZJBKZOZVVCNBR-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361842543P | 2013-07-03 | 2013-07-03 | |
| US61/842,543 | 2013-07-03 | ||
| PCT/US2014/045145 WO2015003002A1 (en) | 2013-07-03 | 2014-07-01 | Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016525092A JP2016525092A (ja) | 2016-08-22 |
| JP2016525092A5 true JP2016525092A5 (OSRAM) | 2017-08-10 |
| JP6647592B2 JP6647592B2 (ja) | 2020-02-14 |
Family
ID=52144176
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016524330A Expired - Fee Related JP6647592B2 (ja) | 2013-07-03 | 2014-07-01 | ピロロピロールカルバメート、および関連する有機化合物、医薬組成物、ならびにその医学的使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9828379B2 (OSRAM) |
| EP (1) | EP3016653A4 (OSRAM) |
| JP (1) | JP6647592B2 (OSRAM) |
| CN (1) | CN105517547A (OSRAM) |
| CA (1) | CA2917050A1 (OSRAM) |
| MX (1) | MX2015017961A (OSRAM) |
| WO (1) | WO2015003002A1 (OSRAM) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013207252B2 (en) | 2012-01-06 | 2016-06-09 | H.Lundbeck A/S | Carbamate compounds and pharmaceutical compositions thereof |
| MX2015017961A (es) | 2013-07-03 | 2016-10-14 | Abide Therapeutics Inc | Compuestos orgánicos pirrolo-pirrol carbamato y relacionados, composiciones farmacéuticas y usos médicos de los mismos. |
| BR112018000041A2 (pt) | 2015-07-31 | 2018-09-04 | Pfizer Inc. | Derivados de carbamato de 1,1,1-trifluoro-3- hidroxipropan-2-ila e derivados de carbamato de 1,1,1-trifluoro-4-hidroxibutan-2-ila como inibidores de magl |
| WO2017143283A1 (en) | 2016-02-19 | 2017-08-24 | Abide Therapeutics, Inc. | Radiolabeled monoacylglycerol lipase occupancy probe |
| ES2861648T3 (es) * | 2016-05-12 | 2021-10-06 | Lundbeck La Jolla Research Center Inc | Compuestos de espirociclo y procedimientos de fabricación y uso de los mismos |
| US10899737B2 (en) | 2016-09-19 | 2021-01-26 | Lundbeck La Jolla Research Center, Inc. | Piperazine carbamates and methods of making and using same |
| JOP20190106A1 (ar) * | 2016-11-16 | 2019-05-09 | Lundbeck La Jolla Research Center Inc | مثبطات أحادي أسيل جليسرول ليباز (magl) |
| CA3043609A1 (en) * | 2016-11-16 | 2018-05-24 | Abide Therapeutics, Inc. | Pharmaceutical formulations |
| JOP20190105A1 (ar) * | 2016-11-16 | 2019-05-09 | Lundbeck La Jolla Research Center Inc | مثبطات أحادي أسيل جليسرول ليباز (magl) |
| UA124585C2 (uk) | 2016-11-16 | 2021-10-13 | Лундбек Ла Джолла Ресеарч Центер, Інк. | Кристалічні форми інгібітора magl |
| JOP20190107A1 (ar) * | 2016-11-16 | 2019-05-09 | Lundbeck La Jolla Research Center Inc | مثبطات أحادي أسيل جليسرول ليباز (magl) |
| SG11201906417RA (en) * | 2017-01-20 | 2019-08-27 | Pfizer | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as magl inhibitors |
| EP4424683A3 (en) * | 2017-03-13 | 2024-11-06 | Lundbeck La Jolla Research Center, Inc. | Dual magl and faah inhibitors |
| PE20200664A1 (es) | 2017-08-29 | 2020-06-11 | Lundbeck La Jolla Research Center Inc | Compuestos espirociclicos y sus metodos de preparacion y uso |
| US11161856B2 (en) * | 2017-08-29 | 2021-11-02 | H. Lundbeck A/S | Spirocycle compounds and methods of making and using same |
| BR112020005720A2 (pt) * | 2017-09-29 | 2020-10-20 | Takeda Pharmaceutical Company Limited | composto ou sal, medicamento, métodos para inibir monoacilglicerol lipase e para a profilaxia ou o tratamento de doença de alzheimer, doença de parkinson, doença de huntington, esclerose lateral amiotrófica, esclerose múltipla, distúrbio de ansiedade, dor, epilepsia ou depressão, e, uso do composto ou sal. |
| EP3793547A4 (en) | 2018-05-15 | 2021-11-17 | H. Lundbeck A/S | MAGL INHIBITORS |
| JP2021531287A (ja) * | 2018-07-19 | 2021-11-18 | ファイザー・インク | Ｍａｇｌ阻害剤としての複素環式スピロ化合物 |
| EP4034116A4 (en) * | 2019-09-26 | 2023-10-25 | The Board of Trustees of the Leland Stanford Junior University | METHODS FOR REDUCING THE GRATIFYING EFFECTS OF MORPHINE WITHOUT AFFECTING ITS ANALGESIC EFFECTS |
| EP4139288A1 (en) | 2020-04-21 | 2023-03-01 | H. Lundbeck A/S | Synthesis of a monoacylglycerol lipase inhibitor |
| UY39516A (es) | 2020-11-13 | 2022-05-31 | H Lundbeck As | Composición para el tratamiento de una enfermedad vascular, composición para la prevención de una enfermedad vascular, composición para el tratamiento de la hipertensión, y composición para la prevención de la hipertensión |
| CN117120435A (zh) * | 2021-04-01 | 2023-11-24 | 小野药品工业株式会社 | Abhd6拮抗剂 |
| US20250084065A1 (en) | 2021-12-29 | 2025-03-13 | Psy Therapeutics, Inc. | Inhibiting monoacylglycerol lipase (magl) |
| CA3250023A1 (en) | 2022-05-04 | 2023-11-09 | H. Lundbeck A/S | CRYSTALLINE FORM OF 1,1,1,3,3,3-HEXAFLUOROPROPAN-2-YL (S)-1-(PYRIDAZINE-3-YLCARBAMOYL)-6 AZASPIRO[2,5]OCTANE-6-CARBOXYLATE AS A MONOACYLGLYCEROL LIPASE INHIBITOR |
| EP4665718A1 (en) | 2023-02-13 | 2025-12-24 | Apogee Pharmaceuticals, Inc. | Small molecules as monoacylglycerol lipase (magl) inhibitors, compositions and use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0100326D0 (sv) * | 2001-02-02 | 2001-02-02 | Astrazeneca Ab | New compounds |
| WO2002070523A1 (en) * | 2001-03-07 | 2002-09-12 | Pfizer Products Inc. | Modulators of chemokine receptor activity |
| US20110071180A1 (en) * | 2008-03-05 | 2011-03-24 | Targacept, Inc. | Sub-type selective amides of diazabicycloalkanes |
| US8653263B2 (en) * | 2009-10-23 | 2014-02-18 | Janssen Pharmaceutica | Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators |
| US9108937B2 (en) * | 2010-03-04 | 2015-08-18 | Merck Sharp & Dohme Corp. | Positive allosteric modulators of mGluR2 |
| EP2444084A1 (en) * | 2010-10-21 | 2012-04-25 | Centro Nacional de Investigaciones Oncológicas (CNIO) | Use of PI3K inibitors for the treatment of obesity |
| PL2900669T3 (pl) * | 2012-09-25 | 2020-01-31 | F. Hoffmann-La Roche Ag | Pochodne heksahydropirolo[3,4-C]pirolu i związki pokrewne jako inhibitory autotaksyny (ATX) oraz inhibitory produkcji kwasu lizofosfatydowego (LPA) do leczenia np. chorób nerek |
| MX2015017961A (es) | 2013-07-03 | 2016-10-14 | Abide Therapeutics Inc | Compuestos orgánicos pirrolo-pirrol carbamato y relacionados, composiciones farmacéuticas y usos médicos de los mismos. |
-
2014
- 2014-07-01 MX MX2015017961A patent/MX2015017961A/es unknown
- 2014-07-01 WO PCT/US2014/045145 patent/WO2015003002A1/en not_active Ceased
- 2014-07-01 JP JP2016524330A patent/JP6647592B2/ja not_active Expired - Fee Related
- 2014-07-01 US US14/902,324 patent/US9828379B2/en not_active Expired - Fee Related
- 2014-07-01 CN CN201480048531.6A patent/CN105517547A/zh active Pending
- 2014-07-01 CA CA2917050A patent/CA2917050A1/en not_active Abandoned
- 2014-07-01 EP EP14820480.3A patent/EP3016653A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016525092A5 (OSRAM) | ||
| JP2018500376A5 (OSRAM) | ||
| US20230234958A1 (en) | Shp2 phosphatase inhibitors and methods of use thereof | |
| JP6435323B2 (ja) | 炎症性障害の治療のための新規化合物及びその医薬組成物 | |
| SI3083625T1 (en) | Pyrimidopyrimidinones, useful as Wee-1 kinase inhibitors | |
| JP2013523884A5 (OSRAM) | ||
| RU2019115115A (ru) | Производные пиперидина в качестве ингибиторов убиквитин-специфической протеазы 7 | |
| JP2019535664A5 (OSRAM) | ||
| HRP20200575T1 (hr) | Spojevi karbamata i postupci pripremanja i korištenja istih | |
| JP2011511034A5 (OSRAM) | ||
| JP2015510938A5 (OSRAM) | ||
| JP2021506858A5 (OSRAM) | ||
| HRP20210177T1 (hr) | Supstituirani spojevi pirazolo[1,5-a]piridina kao inhibitori ret kinaze | |
| JP2011516558A5 (OSRAM) | ||
| FI3436461T3 (fi) | Pyrrolotriatsiiniyhdisteitä tam-inhibiittoreina | |
| JP2014506929A5 (OSRAM) | ||
| JPWO2020005873A5 (OSRAM) | ||
| JP2017530960A5 (OSRAM) | ||
| JP2015522002A5 (OSRAM) | ||
| RU2017105296A (ru) | Новые соединения | |
| HRP20210935T1 (hr) | Spojevi 5-kloro-2-difluorometoksifenil pirazolopirimidina koji predstavljaju inhibitore jak | |
| RU2005117383A (ru) | Производные фенилаланина в качестве ингибиторов дипептидилпептидазы для лечения или профилактики диабета | |
| JP2018527353A5 (OSRAM) | ||
| JPWO2020005877A5 (OSRAM) | ||
| JP2014511355A5 (OSRAM) |